Process Chemistry in the Pharmaceutical Industry, Volume 2

Author:   Kumar Gadamasetti (Delphian Pharmaceuticals, Belmont, California, USA) ,  Kumar Gadamasetti (Delphian Pharmaceuticals, Belmont, California, USA) ,  Tamim Braish
Publisher:   CRC Press
ISBN:  

9781322627564


Pages:   534
Publication Date:   01 January 2007
Format:   Electronic book text
Availability:   In stock   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $831.60 Quantity:  
Add to Cart

Share |

Process Chemistry in the Pharmaceutical Industry, Volume 2


Add your own review!

Overview

As pharmaceutical companies strive to develop safer medicines at a lower cost, they must keep pace with the rapid growth of technology and research methodologies. Defying the misconception of process chemistry as mere scale-up work, Process Chemistry in the Pharmaceutical Industry, Vol. 2: Challenges in an Ever Changing Climate explores novel applications of synthetic, physical, and analytical chemistry in drug discovery and development. It offers an accurate depiction of the most up-to-date process research and development methods applied to synthesis, clinical trials, and commercializing drug candidates. The second installment in this progressive series, this volumereviews the latest breakthroughs to advance process chemistry, including asymmetric synthesis, crystallization, morphology, enzymatic intervention, green chemistry, macromolecules (monoclonal antibodies, biological molecules, polymers), enantioselectivity, organometallic chemistry, process analytical tools, chemical engineering controls, regulatory compliance, and outsourcing/globalization. It explores new approaches to synthetic processes, examines the latest safety methods and experiment design, and suggests realistic solutions to problems encountered in manufacturing and process development. Significant topics include atom economy, ease of synthesis, instrumentation, automization, quality control, cost considerations, green practices, and future trends. Jointly edited by the founder/president of Delphian Pharmaceuticals and the director of Chemical R&D at Pfizer, this book brings together contributions byreputed scientists, technologists, engineers, and professors from leading academic institutions, such as the Imperial College, UK, the University of Tokyo, ETH, Switzerland, the International University at Bermen, Germany, and the University of Connecticut, USA, and from principal pharmaceutical companies that include Merck, Bristol Myers Squibb, Pfizer, Novartis, Eli Lilly, Astrazeneca and DSM.

Full Product Details

Author:   Kumar Gadamasetti (Delphian Pharmaceuticals, Belmont, California, USA) ,  Kumar Gadamasetti (Delphian Pharmaceuticals, Belmont, California, USA) ,  Tamim Braish
Publisher:   CRC Press
Imprint:   CRC Press
ISBN:  

9781322627564


ISBN 10:   1322627568
Pages:   534
Publication Date:   01 January 2007
Audience:   General/trade ,  General
Format:   Electronic book text
Publisher's Status:   Active
Availability:   In stock   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

lgn

al

Shopping Cart
Your cart is empty
Shopping cart
Mailing List